{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:14:17Z","timestamp":1778537657511,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T00:00:00Z","timestamp":1663372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 109-2314-B-039-021-MY3"],"award-info":[{"award-number":["MOST 109-2314-B-039-021-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 111-2314-B-A19-001-MY3"],"award-info":[{"award-number":["MOST 111-2314-B-A19-001-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["109-2635-B-010-002"],"award-info":[{"award-number":["109-2635-B-010-002"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ijrobp.2022.09.060","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T11:15:52Z","timestamp":1663586152000},"page":"719-732","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Lenvatinib Synergistically Promotes Radiation Therapy in Hepatocellular Carcinoma by Inhibiting Src\/STAT3\/NF-\u03baB-Mediated Epithelial\u2013Mesenchymal Transition and Metastasis"],"prefix":"10.1016","volume":"115","author":[{"given":"Yueh-Shan","family":"Weng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-Tsang","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jai-Jen","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2153-340X","authenticated-orcid":false,"given":"Fei-Ting","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2022.09.060_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188391","article-title":"Lenvatinib for hepatocellular carcinoma: From preclinical mechanisms to anti-cancer therapy","volume":"1874","author":"Zhao","year":"2020","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0002","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/ph14010036","article-title":"Lenvatinib for hepatocellular carcinoma: A literature review","volume":"14","author":"Hatanaka","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0003","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: A randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"The Lancet"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0004","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s12072-021-10184-9","article-title":"Lenvatinib in combination with transarterial chemoembolization for treatment of unresectable hepatocellular carcinoma (UHCC): A retrospective controlled study","volume":"15","author":"Fu","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0005","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.3390\/jcm9124121","article-title":"A real-world comparative analysis of lenvatinib and sorafenib as a salvage therapy for transarterial treatments in unresectable HCC","volume":"9","author":"Lee","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110797","article-title":"The safety and efficacy of lenvatinib combined with immune checkpoint inhibitors therapy for advanced hepatocellular carcinoma","volume":"132","author":"Wang","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0007","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1200\/JCO.20.00808","article-title":"Phase Ib study of lenvatinib plus pembrolizumab in patients with unresectable hepatocellular carcinoma","volume":"38","author":"Finn","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0008","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.3390\/ijms21051859","article-title":"Radiosensitization of hepatocellular carcinoma through targeting radio-associated microRNA","volume":"21","author":"Wu","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0009","doi-asserted-by":"crossref","first-page":"183","DOI":"10.14218\/JCTH.2018.00060","article-title":"Role of radiotherapy in the treatment of hepatocellular carcinoma","volume":"7","author":"Chen","year":"2019","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0010","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4254\/wjh.v7.i1.101","article-title":"Role of radiotherapy in the management of hepatocellular carcinoma: A systematic review","volume":"7","author":"Kalogeridi","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0011","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3350\/cmh.2017.0073","article-title":"Strategic application of radiotherapy for hepatocellular carcinoma","volume":"24","author":"Choi","year":"2018","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0012","first-page":"1878","volume":"12","author":"Znati","year":"2020","journal-title":"Radiosensitisation of hepatocellular carcinoma cells by vandetanib. Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0013","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3390\/cancers13020192","article-title":"Stereotactic radiotherapy for hepatocellular carcinoma, radiosensitization strategies and radiation-immunotherapy combination","volume":"13","author":"P\u00e9rez-Romasanta","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0014","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.biopha.2017.09.065","article-title":"Connexin 32 affects doxorubicin resistance in hepatocellular carcinoma cells mediated by Src\/FAK signaling pathway","volume":"95","author":"Yu","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0015","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.3390\/cancers12103025","article-title":"Immune checkpoint inhibitors in hepatocellular carcinoma: Current status and novel perspectives","volume":"12","author":"Federico","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0016","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1038\/s41598-021-81176-w","article-title":"Effect of radiotherapy on survival in advanced hepatocellular carcinoma patients treated with sorafenib: A nationwide cancer-registry-based study","volume":"11","author":"Chu","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0017","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.canlet.2012.10.024","article-title":"Sorafenib potentiates irradiation effect in hepatocellular carcinoma in vitro and in vivo","volume":"329","author":"Yu","year":"2013","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0018","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ijrobp.2013.01.025","article-title":"Sorafenib enhances radiation-induced apoptosis in hepatocellular carcinoma by inhibiting STAT3","volume":"86","author":"Huang","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0019","doi-asserted-by":"crossref","first-page":"85450","DOI":"10.18632\/oncotarget.13398","article-title":"Sorafenib pretreatment enhances radiotherapy through targeting MEK\/ERK\/NF-\u03baB pathway in human hepatocellular carcinoma-bearing mouse model","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0020","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.18632\/oncotarget.6579","article-title":"Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage","volume":"7","author":"Marampon","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0021","first-page":"895","article-title":"Synergistic interaction of anticancer agents: A cellular perspective","volume":"59","author":"Valeriote","year":"1975","journal-title":"Cancer Chemother Rep"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0022","first-page":"2177","article-title":"Chronology of combined chemotherapy (5FU) and radiotherapy. I. In vitro study","volume":"13","author":"Carpentier","year":"1993","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0023","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.synres.2018.04.001","article-title":"The combination index (CI\u00a0<\u00a01) as the definition of synergism and of synergy claims","volume":"7","author":"Chou","year":"2018","journal-title":"Synergy"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0024","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ijrobp.2019.11.013","article-title":"Using the radiosensitivity index (RSI) to predict pelvic failure in endometrial cancer treated with adjuvant radiation therapy","volume":"106","author":"Mohammadi","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110319","article-title":"Regorafenib suppresses epidermal growth factor receptor signaling-modulated progression of colorectal cancer","volume":"128","author":"Liu","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110054","article-title":"Beneficial effect of fluoxetine on anti-tumor progression on hepatocellular carcinoma and non-small cell lung cancer bearing animal model","volume":"126","author":"Hsu","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0027","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1091\/mbc.e06-04-0263","article-title":"Loss of caspase-9 reveals its essential role for caspase-2 activation and mitochondrial membrane depolarization","volume":"18","author":"Samraj","year":"2007","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0028","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fcell.2020.00041","article-title":"Molecular mechanisms of radiation-induced cancer cell death: A primer","volume":"8","author":"Sia","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0029","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1634\/theoncologist.2009-0009","article-title":"The role of Src in solid tumors","volume":"14","author":"Wheeler","year":"2009","journal-title":"Oncologist"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0030","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1155\/2011\/946295","article-title":"Crosstalk between activated and inactivated c-Src in hepatocellular carcinoma","volume":"30","author":"Chen","year":"2011","journal-title":"Dis Markers"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0031","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.3390\/cancers11081053","article-title":"Context-dependent role of NF-\u03baB signaling in primary liver cancer-from tumor development to therapeutic implications","volume":"11","author":"Czauderna","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0032","doi-asserted-by":"crossref","first-page":"743","DOI":"10.21873\/anticanres.14005","article-title":"Hepatic stellate cells contribute to the tumor malignancy of hepatocellular carcinoma through the IL-6 pathway","volume":"40","author":"Iwahasi","year":"2020","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0033","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/cr.2010.183","article-title":"NF-\u03baB and STAT3 - key players in liver inflammation and cancer","volume":"21","author":"He","year":"2011","journal-title":"Cell Res"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0034","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1158\/1078-0432.CCR-15-0780","article-title":"Severe hepatitis promotes hepatocellular carcinoma recurrence via NF-\u03baB pathway-mediated epithelial-mesenchymal transition after resection","volume":"22","author":"Wu","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0035","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.3390\/cancers11111646","article-title":"Stat3: An emerging therapeutic target for hepatocellular carcinoma","volume":"11","author":"Lee","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0036","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4252\/wjsc.v5.i4.188","article-title":"Epithelial-mesenchymal transition - activating transcription factors - multifunctional regulators in cancer","volume":"5","author":"Garg","year":"2013","journal-title":"World J Stem Cells"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0037","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.drudis.2020.11.032","article-title":"Role of STAT3 signaling transduction pathways in cancer stem cell-associated chemoresistance","volume":"26","author":"Shih","year":"2021","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0038","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1158\/1541-7786.MCR-13-0189","article-title":"The role of inflammatory pathways in cancer-associated cachexia and radiation resistance","volume":"11","author":"Laine","year":"2013","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0039","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.3390\/ijms17111899","article-title":"Berberine suppresses cyclin D1 expression through proteasomal degradation in human hepatoma cells","volume":"17","author":"Wang","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0040","first-page":"209","article-title":"Serum VEGF level is associated with the outcome of patients with hepatocellular carcinoma: A meta-analysis","volume":"2","author":"Zhan","year":"2013","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"Suppl 3","key":"10.1016\/j.ijrobp.2022.09.060_bib0041","doi-asserted-by":"crossref","first-page":"S375","DOI":"10.1245\/s10434-011-1836-7","article-title":"The significance of MMP-9 over MMP-2 in HCC invasiveness and recurrence of hepatocellular carcinoma after curative resection","volume":"19","author":"Chen","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0042","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1038\/sj.onc.1209706","article-title":"Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K\/Akt\/NF-kappaB signal transduction pathway","volume":"25","author":"Cheng","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0043","doi-asserted-by":"crossref","first-page":"16328","DOI":"10.1038\/s41598-020-73310-x","article-title":"VEGF knockdown enhances radiosensitivity of nasopharyngeal carcinoma by inhibiting autophagy through the activation of MTOR pathway","volume":"10","author":"Chen","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0044","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1158\/1078-0432.CCR-07-2060","article-title":"Matrix metalloproteinase-9 inhibition down-regulates radiation-induced nuclear factor-kappa B activity leading to apoptosis in breast tumors","volume":"14","author":"Kunigal","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0045","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/cancers10020052","article-title":"The epithelial-to-mesenchymal transition in cancer","volume":"10","author":"Roche","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0046","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev-pathol-020117-043854","article-title":"Epithelial mesenchymal transition in tumor metastasis","volume":"13","author":"Mittal","year":"2018","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0047","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1245\/s10434-014-3779-2","article-title":"Epithelial to mesenchymal transition is associated with shorter disease-free survival in hepatocellular carcinoma","volume":"21","author":"Yamada","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.102961","article-title":"The role of epithelial-mesenchymal transition in regulating radioresistance","volume":"150","author":"Zhou","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0049","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2147\/OTT.S237410","article-title":"Silencing snail reverses epithelial-mesenchymal transition and increases radiosensitivity in hypopharyngeal carcinoma","volume":"13","author":"Wang","year":"2020","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.ijrobp.2022.09.060_bib0050","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/15384101.2015.1006048","article-title":"Zeb1: At the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance","volume":"14","author":"Zhang","year":"2015","journal-title":"Cell Cycle"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301622033521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301622033521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T21:45:03Z","timestamp":1778535903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301622033521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0360301622033521"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2022.09.060","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lenvatinib Synergistically Promotes Radiation Therapy in Hepatocellular Carcinoma by Inhibiting Src\/STAT3\/NF-\u03baB-Mediated Epithelial\u2013Mesenchymal Transition and Metastasis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2022.09.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}